PEC-PRO: A new prognostic score from a series of 87 patients with localized perivascular epithelioid cell neoplasms (PEComas) treated with curative intent.
Justine GantzerMaud ToulmondeFrançois SeveracAli N ChamseddineCéline Charon-BarraCharles VinsonAlice HervieuAgathe BourgmayerFrançois BertucciThomas RyckewaertThibaud ValentinNelly FirminLoïc ChaigneauEmmanuelle BompasPhilippe FollanaNathalie Rioux-LeclercqPauline Soibinet-OudotLaurence BozecFrançois Le LoarerNoëlle WeingertnerChristine ChevreauFlorence DuffaudJean Yves BlayJean-Emmanuel KurtzPatrick SchöffskiMehdi BrahmiGabriel G MaloufPublished in: Cancer (2024)
The PEC-PRO score reliably predicts the risk of postoperative recurrence in patients with localized PEComa. It has the potential to improve follow-up strategies but requires validation in a prospective trial.